Back
InflaRx NV 10K Form
Sell
17
IFRX
InflaRx NV
Last Price:
$0.91
Seasonality Move:
17.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IFRX News And Ratings
See the #1 stock for the next 7 days that we like better than IFRX
IFRX Financial Statistics
Sales & Book Value
| Annual Sales: | $33.1K |
|---|---|
| Cash Flow: | $-11.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.79 |
| Price / Book: | 1.24 |
Profitability
| EPS (TTM): | -0.91660 |
|---|---|
| Net Income (TTM): | $-58.6M |
| Gross Margin: | $-8.6M |
| Return on Equity: | -82.01% |
| Return on Assets: | -65.78% |
InflaRx NV Earnings Forecast
Key InflaRx NV Financial Ratios
-
The Gross Profit Margin over the past 5 years for IFRX is -26,017.22%.
-
The Selling, General & Administrative Expenses for IFRX have been equal to 61,226.59% of Gross Profit Margin.
-
The Research & Development expenses have been 87,697.58% of Revenue.
-
The Net Earning history of IFRX is -155,593.05% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
InflaRx NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IFRX |
| CUSIP: | N44821 |
| Website: | inflarx.de |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 3.33 |
| Quick Ratio: | 2.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IFRX Technical Analysis vs Fundamental Analysis
Sell
17
InflaRx NV (IFRX)
is a Sell
Is InflaRx NV a Buy or a Sell?
-
InflaRx NV stock is rated a SellThe current InflaRx NV [IFRX] share price is $0.91. The Score for IFRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.